Diversity in coronary artery disease treatment

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: A. B. Cid Alvarez, M. Tscharre, E. O. Fosse

Speakers: A. I. Ishraga, X. Bian, K. MD, J. He

Summary

Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis in diverse healthcare settings, emphasizing the multifaceted nature of CAD management across different populations.

Presentations available when logged in:

T2DM modifies prognostic value of LDL particle size in statin-treated coronary artery disease patients undergoing PCI
Clinical outcome of stent thrombosis in a tertiary cardiac care hospital of Bangladesh

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Diversity in coronary artery disease treatment

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free